Skip to main content
logo
Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.7803
+0.0122 (1.59%)
At close: Jul 17, 2026, 4:00 PM EDT
0.7900
+0.0097 (1.24%)
After-hours: Jul 17, 2026, 7:57 PM EDT

Celularity Revenue

In the year 2025, Celularity had annual revenue of $26.55M, down -51.03%. Celularity had revenue of $4.10M in the quarter ending December 31, 2025, a decrease of -77.37%.

Revenue (ttm)
$37.98M
Revenue Growth
-44.88%
P/S Ratio
0.85
Revenue / Employee
$230,870
Employees
115
Market Cap
22.59M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202526.55M-27.67M-51.03%
Dec 31, 202454.22M31.45M138.11%
Dec 31, 202322.77M4.80M26.68%
Dec 31, 202217.98M-3.36M-15.75%
Dec 31, 202121.34M7.06M49.43%
Dec 31, 202014.28M--
Dec 31, 2019---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Plus Therapeutics5.18M
Marker Therapeutics3.55M
IGC Pharma1.11M
Pluri1.08M
VYNE Therapeutics454.00K
Revenue Rankings

CELU News

More News